Google has just two weeks to begin cracking open Android, it admits in emergency filing
Today, Google admits the answer is: 14 days. Google has just 14 days to enact major changes to its Google Play app store, and the way it does business with phonemakers, cellular carriers, and app developers, unless it wins an emergency stay (pause) from the Ninth Circuit Court of Appeals as it continues to appeal. It must stop forcing apps to use Google Play Billing, allow app developers to freely steer their users to other platforms, and limit the perks it can offer in exchange for preinstalled apps, among other changes.
Those changes would not yet include Epic's biggest wins. They don't yet force Google to carry rival app stores within the Google Play Store, or to share its full app catalog with those rival stores, so don't expect the Epic Games Store or the Microsoft Xbox Store to appear inside Google Play quite yet.
When he issued the permanent injunction to begin cracking open Android, Judge James Donato gave Google eight months to come up with a 'narrowly tailored' system of safety and security procedures before it would be forced to carry rival app stores, and Google has seven and a half months left now the previous stay has been lifted. So rival app stores won't appear inside Google Play until 2026 at the earliest.
But according to Google's emergency stay request, it believes other changes are required far faster: 'the remedies in 4-7, 9-10, and 13 of the District Court's injunction will go into effect in 14 days.' Google claims this is an emergency because it'll have a 'significant impact' on 'millions of Google's users and over 500,000 app developers—as well as Google itself,' and that 'requiring these changes to be imposed in only 14 days would expose users and developers to substantial risks and jeopardize the entire Android ecosystem.'
So, which remedies are 4-7, 9, 10, and 13? They're the ones that:
Some of these provisions mirror changes that Epic scored in its otherwise mostly unsuccessful antitrust suit against Apple. They take on what are known as anti-steering rules — policies that, now in two major cases, courts have agreed unfairly limit developers' access to a competitive market.
I've copied each of those required remedies out of Judge Donato's injunction so you can read for yourself:
4. For a period of three years ending on November 1, 2027, Google may not share revenue generated by the Google Play Store with any person or entity that distributes Android apps, or has stated that it will launch or is considering launching an Android app distribution platform or store.
5. For a period of three years ending on November 1, 2027, Google may not condition a payment, revenue share, or access to any Google product or service, on an agreement by an app developer to launch an app first or exclusively in the Google Play Store.
6. For a period of three years ending on November 1, 2027, Google may not condition a payment, revenue share, or access to any Google product or service, on an agreement by an app developer not to launch on a third-party Android app distribution platform or store a version of an app that includes features not available in, or is otherwise different from, the version of the app offered on the Google Play Store.
7. For a period of three years ending on November 1, 2027, Google may not condition a payment, revenue share, or access to any Google product or service, on an agreement with an original equipment manufacturer (OEM) or carrier to preinstall the Google Play Store on any specific location on an Android device.
9. For a period of three years ending on November 1, 2027, Google may not require the use of Google Play Billing in apps distributed on the Google Play Store, or prohibit the use of in-app payment methods other than Google Play Billing. Google may not prohibit a developer from communicating with users about the availability of a payment method other than Google Play Billing. Google may not require a developer to set a price based on whether Google Play Billing is used.
10. For a period of three years ending on November 1, 2027, Google may not prohibit a developer from communicating with users about the availability or pricing of an app outside the Google Play Store, and may not prohibit a developer from providing a link to download the app outside the Google Play Store.
13. Within thirty days of the date of this order, the parties will recommend to the Court a three-person Technical Committee. Epic and Google will each select one member of the Technical Committee, and those two members will select the third member. After appointment by the Court, the Technical Committee will review disputes or issues relating to the technology and processes required by the preceding provisions. If the Technical Committee cannot resolve a dispute or issue, a party may ask the Court for a resolution. The Technical Committee may not extend any deadline set in this order, but may recommend that the Court accept or deny a request to extend. Each party will bear the cost of compensating their respective party-designated committee member for their work on the committee. The third member's fees will be paid by the parties in equal share.
We've asked Google how any of these remedies might 'expose users and developers to substantial risks,' and we'll let you know what we hear.
The three-judge Ninth Circuit panel denied Google's earlier motion for a stay, and affirmed that all parts of Judge Donato's permanent injunction were valid and appropriate, so I'm not sure why it would approve this stay instead. However, Google is signaling that it could appeal to both the full Ninth Circuit, and to the Supreme Court.
You can read Google's full emergency stay request below:
Posts from this author will be added to your daily email digest and your homepage feed.
See All by Sean Hollister
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Android
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Antitrust
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Apps
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Google
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Mobile
Posts from this topic will be added to your daily email digest and your homepage feed.
See All News
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Policy
Posts from this topic will be added to your daily email digest and your homepage feed.
See All Tech
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Alcon Agrees to Acquire STAAR Surgical
STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon's laser vision correction business and is expected to be accretive in year two Alcon to purchase all outstanding shares of STAAR for $28 per share in cash, valuing STAAR at approximately $1.5 billion in equity value Ad Hoc Announcement Pursuant to Art. 53 LR GENEVA & LAKE FOREST, Calif., August 05, 2025--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), today announced the companies have entered into a definitive merger agreement through which Alcon intends to acquire STAAR. The acquisition includes the EVO family of lenses (EVO ICL™) for vision correction for patients with moderate to high myopia (nearsightedness), with or without astigmatism. Under the terms of the agreement, Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which represents approximately a 59% premium to STAAR's 90-day Volume Weighted Average Price (VWAP) and a 51% premium to the closing price of STAAR common stock on August 4, 2025. The transaction represents a total equity value of approximately $1.5 billion. "With the number of high myopes rising globally, the acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK," said David Endicott, CEO of Alcon. "This transaction will allow us to provide treatment options across the full spectrum of myopia—from contact lenses to surgical interventions—reinforcing our commitment to addressing the most significant needs in eye care." An estimated 50% of the world will be myopic by 2050 and today nearly 500 million people are considered high myopes.1 With its innovative design, the EVO family of ICLs are implantable lenses that address a wide range of vision correction needs, including myopia with and without astigmatism, through a minimally invasive procedure that is reversible. The EVO family of ICLs are implanted between the iris (the colored part of the eye) and the natural crystalline lens during a procedure that does not remove corneal tissue. "We believe the transaction with Alcon represents the best path forward and provides the greatest value for STAAR shareholders," said Stephen Farrell, CEO of STAAR. "As we've shared, fluctuating demand in China over the past two years has continued to create significant headwinds for STAAR as a standalone company. I'm proud of our team's efforts to address recent challenges, but there is more work to do. As a significantly larger company, Alcon has the capabilities and scale to accelerate EVO ICL adoption and bring our innovative technology to more surgeons and patients worldwide." Dr. Elizabeth Yeu, Chair of the STAAR Board of Directors, said, "The STAAR Board is committed to maximizing value for shareholders. We have determined that this carefully negotiated transaction is in the best interest of STAAR shareholders as it delivers immediate and certain value at a significant premium, value that exceeds what we believe could be achieved under STAAR's standalone strategy." The transaction is not subject to a financing condition. Alcon intends to finance the transaction through the issuance of short- and long-term credit facilities. The transaction is anticipated to close in approximately six to 12 months, subject to customary closing conditions, including regulatory approval and approval by STAAR's shareholders. The transaction is expected to be accretive to earnings in year two. The Boards of Directors of Alcon and STAAR have each unanimously approved the transaction. Morgan Stanley & Co. LLC is serving as financial advisor to Alcon, and Gibson, Dunn & Crutcher LLP is serving as legal advisor to Alcon. Citi is serving as the exclusive financial advisor to STAAR, and Wachtell, Lipton, Rosen & Katz is serving as legal advisor to STAAR. As previously announced, STAAR will release financial results for its second quarter that ended June 27, 2025, on Wednesday, August 6, 2025, after the market close. Given the pending acquisition by Alcon, STAAR will not host a conference call in conjunction with earnings. Forward-looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the potential transaction between Alcon and STAAR and the expected timing, impacts and benefits thereof, Alcon's and STAAR's business strategies, performance, market adoption and estimates of market size. In some cases, you can identify forward-looking statements by terms such as "aim," "anticipate," "approach," "believe," "contemplate," "could," "estimate," "expect," "goal," "intend," "look," "may," "mission," "plan," "possible," "potential," "predict," "project," "pursue," "should," "target," "will," "would," or the negative thereof and similar words and expressions. Forward-looking statements are based on Alcon's and STAAR's management's current expectations, beliefs and assumptions and on information currently available to us. Such statements are subject to a number of known and unknown risks, uncertainties and assumptions. The following factors could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: (i) the proposed merger may not be completed in a timely manner or at all, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect STAAR or the expected benefits of the proposed merger or that the approval of STAAR's stockholders is not obtained; (ii) the failure to realize the anticipated benefits of the proposed merger; (iii) the possibility that competing offers or acquisition proposals for STAAR will be made; (iv) risks that third parties and/or STAAR stockholders may oppose consummation of the proposed merger on the proposed terms or at all; (v) the possibility that any or all of the various conditions to the consummation of the merger may not be satisfied or waived (vi) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger, including in circumstances which would require either party to pay a termination fee; (vii) the effect of the announcement or pendency of the merger on STAAR's ability to retain and hire key personnel, STAAR's ability to retain key customers, suppliers or distributors or its operating results and business generally, (viii) there may be liabilities related to the merger that are not known, probable or estimable at this time or unexpected costs, charges or expenses; (ix) the merger may result in the diversion of management's time and attention to issues relating to the merger; (x) there may be significant transaction costs in connection with the merger; (xi) legal proceedings may be instituted against STAAR following the announcement of the merger, which may have an unfavorable outcome; and (xii) STAAR's stock price may decline significantly if the merger is not consummated. In addition, a number of other important factors could cause actual future results and other future circumstances to differ materially from those expressed in any forward-looking statements, including but not limited to those important factors discussed under the heading "Risk Factors" contained in Alcon's Annual Report on Form 20-F for the fiscal year ended December 31, 2024 and in STAAR's Annual Report on Form 10-K for the fiscal year ended December 27, 2024, each as filed with the Securities and Exchange Commission ("SEC"), as such factors may be updated from time to time in such company's other filings with the SEC, accessible on the SEC's website at and the Investor Relations section of STAAR's website at and Alcon's website at All forward-looking statements are expressly qualified in their entirety by such factors. Except as required by law, neither Alcon nor STAAR undertake any obligation to publicly update or review any forward-looking statement, whether because of new information, future developments or otherwise. These forward-looking statements should not be relied upon as representing Alcon's or STAAR's views as of any date subsequent to the date of this press release. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at About STAAR Surgical STAAR Surgical (NASDAQ: STAA) is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic surgery, and for 30 years, STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer® Lenses (ICLs), using its proprietary biocompatible Collamer material. STAAR ICL's are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye's natural crystalline lens. Its EVO ICL™ product line provides visual freedom through a quick, minimally invasive procedure. STAAR has sold more than 3 million ICLs in over 75 countries. Headquartered in Lake Forest, California, the company operates research, development, manufacturing, and packaging facilities in California and Switzerland. For more information about ICL, visit To learn more about STAAR, visit Important Safety Information for the EVO Family of ICLs The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If patients have nearsightedness within these ranges, EVO Visian ICL surgery may improve distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, patients may require them at some point, even if they have never worn them before. Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Patients should discuss the risks with their eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. For additional information with potential benefits, risks and complications please visit Additional Information This press release may be deemed solicitation material in respect of the proposed acquisition of STAAR. A special stockholder meeting will be announced soon to obtain stockholder approval in connection with the proposed merger. STAAR expects to file with the SEC a proxy statement and other relevant documents in connection with the proposed merger. Investors of STAAR are urged to read the definitive proxy statement and other relevant materials carefully and in their entirety when they become available because they will contain important information about the Company and the proposed merger. Investors may obtain a free copy of these materials (when they are available) and other documents filed by STAAR with the SEC at the SEC's website at and at STAAR's website at No Offer or Solicitation This communication is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. Participants in the Solicitation Alcon, STAAR and certain of their respective directors, executive officers and other members of management and employees may be deemed to be participants in soliciting proxies from its stockholders in connection with the proposed merger. Information regarding Alcon's directors and executive officers is contained in Alcon's annual report on Form 20-F for its fiscal year ended December 31, 2024, which was filed with the SEC on February 25, 2025. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of STAAR's stockholders in connection with the proposed merger will be set forth in STAAR's definitive proxy statement for its special stockholder meeting. Additional information regarding these individuals and any direct or indirect interests they may have in the proposed merger will be set forth in the definitive proxy statement when and if it is filed with the SEC in connection with the proposed merger. References Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Brien A Holden at al. Ophthalmology. 2016 May;123(5):1036-42. Connect with us on Facebook LinkedIn View source version on Contacts Alcon Investor Relations Daniel Cravens, Allen Trang+ 41 589 112 110 (Geneva)+ 1 817 615 2789 (Fort Worth) Alcon Media Relations Steven Smith+ 41 589 112 111 (Geneva)+ 1 817 551 8057 (Fort Worth) STAAR Investor & Media Relations Niko Liu, CFAUnited States: 626-303-7902 ext 3023Hong Kong: +852-6092-5076nliu@ investorrelations@ Connie Johnson+1 626 303 7902 (x-2207)cjohnson@
CBS News
5 minutes ago
- CBS News
Mario Lemieux's bid to buy back the Penguins is not close to estimated team value, report says
Mario Lemieux's bid to buy back the Pittsburgh Penguins does not come close what the team's estimated value is likely worth, according to a new report. Earlier this summer, it was reported that Lemieux, along with Ron Burkle and David Morehouse, were interested in buying the team back from the Fenway Sports Group, who purchased the team in 2021. Lemieux and Burkle sold the Penguins to FSG for just shy of $1 billion and last month, it was reported that the Lemieux group was considering its financial options that could lead to taking control of the Penguins again at some point. A new report from Sportsnet insider Elliotte Friedman suggests that the Lemieux group's bid for the team isn't close to FSG's apparent asking price. The only thing I've heard about that so far is that they're just well below what Fenway would want to be the number," Friedman said on his 32 Thoughts podcast. DK Pittsburgh Sports reported last month that the Lemieux group was prepared to buy somewhere in the range of $1 billion for the team. The Penguins were valued at $1.75 billion in the latest Forbes rankings in the fall of 2024, which came in the midst of franchise values skyrocketing across the National Hockey League. Friedman also referenced the recent $1.8 billion sale of the Tampa Bay Lightning, suggesting that price point could be "where the Penguins would want to be."
WIRED
5 minutes ago
- WIRED
Best Hungryroot Promo Codes and Discounts for August 2025
Get up to 30% off your first order and free gifts using a Hungryroot promo code today. Discover our best coupons and discounts to let you save on your healthy groceries as a new or returning customer. All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. A lot of the best meal kits offer the satisfaction of making a home-cooked meal, the chance to learn a little culinary craft, maybe even a chance at some pride in your handiwork. Hungryroot (7/10, WIRED Review) isn't really like that. Hungryroot instead wants to replace your trip to the grocery store with a few good recipes. After starting as a grocery service, Hungryroot spent years piecing together proprietary AI long before AI became the byword of everything from your electric shaver to your literal kitchen sink. What Hungryroot's AI does is geared to creating personalized food menus and shopping lists, based on your every micro-preference and whim, whether that's a love of olives or a hatred of figs. A box then shows up at your door, with a mix of basic provisions, silly snacks, and desserts, along with recipes and usually some pre-prepped ingredients. Cooking is often more assembly, with recipes pieced together from premium ingredients you'd expect to find at your local organic store. A fun sauce here, a pre-cooked protein there, a corn tortilla that just wants to be livened in the pan. Most meals come together in 15 or 20 minutes, in my experience—unless they need time in the oven. A bot concierge and pre-mixed sauces do cost a bit, however, and that's where Hungryroot promo codes come in. There are Hungryroot coupons that offer 30% off or more, and Hungryroot coupon codes that offer extra free gifts for every box, for life: a protein here, a cookie there. Here's what's up. Get 30% Off Plus a Free Gift With a Hungryroot First-Time Discount The current Hungryroot discount code is good for a cool 30% off your first week's box from Hungryroot. To qualify for the discount, you'll need to sign up for a plan totaling $99 or more a week, including breakfast items, snacks, and produce in addition to recipes and ingredients. The Hungryroot promo offer also includes a free gift, which usually includes an option to get an extra premium protein like chicken or beef. You can see more information here. Take Advantage of Hungryroot Coupons for Referrals Like a lot of meal kits, there's also a Hungryroot discount code for referring your friends to the Hungryroot service—and this usually benefits both sides of the equation. Your friend who orders after using your referral code gets a cool $50 off their first grocery delivery of $100 or more—which adds up, potentially, to half off. The person who refers their friend also gets $50 off their next order, once their friend finalizes their first grocery delivery of $100 or more. So basically, everybody gets $50. Follow this link for info on the Hungryroot referral program. Unlike other offers, the referral credits seem to be stackable with other offers—so you don't miss out on any discounts by taking a referral. Take Advantage of Hungryroot Coupons for New and Returning Customers Most subscription services have hidden levels. The way to access them is to change your mind a lot. Just like some magazine subscriptions and almost all delivery meal kits and grocery subscription services, Hungryroot will chase you down with offers if you cancel a subscription or change your mind after already giving them your email. What's this mean? Usually, it means that in the days or weeks after changing your mind about Hungryroot, you'll get a coupon in the mail. So if you take Hungryroot's quiz about your dietary preferences, then don't order? A few days later, you'll likely get a sweet Hungryroot coupon code in your inbox. New subscription plans usually also come with free treats. If you cancel or pause an existing account, you may also receive a Hungryroot promo code offering your $50 or even $100 off your next order, as an incentive to return. Hungryroot retention offers will be different for each customer vary per customer, because offers are usually customized to previous orders—or the answers you gave on Hungryroot's culinary preferences quiz. Get Free Gifts for Life With Hungryroot New HungryRoot customers almost always will get a promo code for a free gift. In some ways, choose carefully: This gift remains steady, as a 'lifetime' offer. Generally you'll choose among fresh produce, a premium protein, or just some tasty pre-packaged snacks. These will keep arriving with every delivery: Make sure it's something you like! Click here for more information about free Hungryroot gifts.
